COMP vs SRPT · rev $5.63B vs rev $1.90B
Compass Inc (COMP) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Compass Inc (COMP) is a real estate services company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported COMP revenue for 2024-12-31 was $5.63B. Net income was -$154.5M. Revenue was up 15.2% from 2023-12-31 to 2024-12-31. COMP currently screens at market cap $3.35B.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
COMP currently screens at market cap $3.35B. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the COMP and SRPT stock pages for the full models.
Not investment advice.